Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda

[1]  V. Beral,et al.  Risk factors for Kaposi's sarcoma: A case‐control study of HIV‐seronegative people in Uganda , 2003, International journal of cancer.

[2]  John Ziegler,et al.  The sero‐epidemiology of Kaposi's sarcoma‐associated herpesvirus (KSHV/HHV‐8) in adults with cancer in Uganda , 2003, International journal of cancer.

[3]  L. Abel,et al.  High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population. , 2002, Journal of the National Cancer Institute.

[4]  V. Beral,et al.  The epidemiology of conjunctival squamous cell carcinoma in Uganda , 2002, British Journal of Cancer.

[5]  J. Dillner,et al.  Viral Load of Human Herpesvirus 8 in Peripheral Blood of Human Immunodeficiency Virus-Infected Patients with Kaposi's Sarcoma , 2001, Journal of Clinical Microbiology.

[6]  V. Beral,et al.  A case‐control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda , 2001, International journal of cancer.

[7]  E. Nicastri,et al.  Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. , 1999, Journal of the National Cancer Institute.

[8]  V. Beral,et al.  Antibodies against human herpesvirus 8 in black South African patients with cancer. , 1999, The New England journal of medicine.

[9]  V. Beral,et al.  Risk factors for Kaposi's sarcoma in HIV‐positive subjects in Uganda , 1997, AIDS.

[10]  A. Buchbinder,et al.  Clinical aspects of epidemic Kaposi's sarcoma. , 1991, Cancer surveys.